PATENT CLAIM ANALYSIS

Application Number: 16254449
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["546", "243000"]

Abstract:
Compounds of formula A-I and B-I, compositions comprising the compounds, methods of making the compounds and methods of their uses are disclosed.

Claim (Index 14):
The method of  claim 1 , wherein the leukemia is relapsed, refractory or resistant to conventional therapy.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 99.0
- Lexical Diversity: 1.38889
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15908366', '15400208', '15275045', '14795837', '15723065']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8266270455452105
- 35 USC 102 Novelty (BERT): 0.6222122275102774
- Combined Prediction Score: 0.8061855637417171
- Mean Citation Score: 506.04698
- Max Citation Score: 633.24915
- Similarity Product: 495.9360655026019

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test